1. Home
  2. Q vs ILMN Comparison

Q vs ILMN Comparison

Compare Q & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Q

Qnity Electronics Inc.

N/A

Current Price

$155.67

Market Cap

23.4B

Sector

Technology

ML Signal

N/A

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$163.69

Market Cap

21.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
Q
ILMN
Founded
2024
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.4B
21.8B
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
Q
ILMN
Price
$155.67
$163.69
Analyst Decision
Strong Buy
Hold
Analyst Count
5
17
Target Price
$119.80
$124.24
AVG Volume (30 Days)
1.6M
1.6M
Earning Date
05-12-2026
04-30-2026
Dividend Yield
0.23%
N/A
EPS Growth
N/A
170.87
EPS
N/A
0.87
Revenue
N/A
$4,343,000,000.00
Revenue This Year
$9.87
$6.47
Revenue Next Year
$7.64
$5.58
P/E Ratio
$29.99
$181.99
Revenue Growth
N/A
N/A
52 Week Low
$72.81
$78.80
52 Week High
$171.52
$158.62

Technical Indicators

Market Signals
Indicator
Q
ILMN
Relative Strength Index (RSI) 55.79 79.12
Support Level $141.57 $116.54
Resistance Level $171.52 N/A
Average True Range (ATR) 7.49 5.67
MACD -0.63 1.56
Stochastic Oscillator 48.81 92.24

Price Performance

Historical Comparison
Q
ILMN

About Q Qnity Electronics Inc.

Qnity is a specialty chemicals company created in 2025 after being spun off from DuPont. It sells chemicals and materials to the semiconductor industry, which generates the majority of sales, and also the electronics industry. Qnity specializes in materials science, including supplying key materials required to manufacture semiconductors and interconnected devices.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: